Masimo O3®'s delta hemoglobin parameters have received FDA clearance for cerebral and somatic applications and all patient ...

Masimo (Nasdaq: MASI) announced today that it received FDA 510(k) clearance for expanded indications for its O3 regional ...

Masimo ( ($MASI) ) has provided an announcement. On August 18, 2025, William Jellison resigned from the Board of Directors of Masimo Corporation, ...

Medical technology company Masimo has been facing off with Apple in court since 2020, and while Masimo has scored some wins, ...

Apple, Masimo, and most importantly users all suffered from this bizarre legal wrangle. How did it get this far?

Masimo (MASI) announced the FDA 510(k) clearance of expanded indications for the delta hemoglobin parameters provided with O3 Regional Oximetry.

Apple will bring back the blood oxygen measurement feature to some of its watch models via a software update after receiving ...

The pulse oximeter maker is now fully operational after a spring cyberattack and increased its 2025 profit forecast, but ...

The company said it would issue a software update to restart the technology, which was caught up in a patent dispute.

“Masimo and Politan need to find a different way out of the $450 million hole, because trying to malign a professional and well respected firm like RTW Investments will not work,” says Sanford ...

Masimo, best known for its successful patent litigation over the Apple Watch, was initially targeted by Politan last year due to what the activist viewed as bad management, a lack of independent ...

For over three years now, Apple has been entrenched in a messy legal battle over a single feature on the Apple Watch — and Apple’s opponent, medical device maker Masimo, seems confident it can ...